Biosearch Technologies has been selected for two Small Business Innovative Research (SBIR) grants from the Department of Defense (DoD). Both Phase 1 grants calls for the development of highly sensitive analyte specific reagents (ASRs) for a total of twelve pathogens. The ASRs are qPCR based, but modified for field deployment. Both grants include the following target pathogens: Dengue, Rift Valley Fever, Sand Fly Fever, Crimean-Congo Hemorrhagic Fever, Tick-Borne Encephalitis, Chikungunya, causative agents of typhus, spotted fever, anaplasmosis, Ehrlichioses, and Q fever. If Phase I turns out to be a success, Biosearch expects this project to lead into a multiyear Phase II award.
To read the entire story, read the full press release.
Or, read more about the products and services Biosearch offers for ASR manufacturing.